The fusion (F) protein is an important membrane glycoprotein necessary for cellular entry and replication of human metapneumovirus (hMPV). Selective prevention of N-linked glycosylation may compromise the catalytic and fusion functions of the F protein. By using site-directed mutagenesis and reverse genetics, recombinant mutant viruses lacking one or two N-linked glycosylation sites in the F protein were constructed. M1, which lacked glycosylation at position 57 of the F protein, had slightly compromised replication, whereas M2 and M4, which lacked glycosylation at position(s) 172 or 57 and 172, respectively, showed profound impairment of replication when compared with wild-type (WT) NL/1/00-GFP virus in both Vero E6 cells and mouse lungs. M2 was less fit than WT virus in vitro and in immunocompromised mouse lungs. The F proteins of WT and mutant viruses were similarly expressed on the infected cell membrane, while the activated fusion protein subunits, F1 of M2 and M4, were produced in lower quantities compared with those of WT and M1 virus. The mutated viruses lacking N-linked glycosylation at position 353, either individually or together with other sites, could not be recovered. Thus, Nlinked glycosylation may be involved in the catalysis of the fusion protein from F0 to F1 and F2, which is critical for fusion function. Strategies targeting N-linked glycosylation may be helpful for developing attenuated live vaccines or antiviral drugs for hMPV.
INTRODUCTION
Human metapneumovirus (hMPV) is a member of the subfamily Pneumovirinae of the family Paramyxoviridae. Since it was discovered, hMPV has been associated with respiratory infections, especially in children. Clinical studies have shown that hMPV infection results in high morbidity in infants and high-risk populations with other underlying medical conditions such as prematurity, asthma, cardiopulmonary disease and immune deficiency. Hospitalization for hMPV infection in previously healthy infants or high-risk populations is comparable to that caused by other common respiratory viruses such as respiratory syncytial virus, parainfluenza virus and influenza virus (van den Hoogen et al., 2001; Boivin et al., 2002) . Our previous study also showed that the morbidity of lower respiratory infection in childhood in southwestern China was largely attributable to hMPV (Chen et al., 2010) . Therefore, it is imperative that an effective hMPV vaccine be developed (Jeffrey, 2006) . hMPV has a negative-sense, ssRNA genome of~13 kbp which encodes nine proteins. Two of these are major membrane-anchored glycoproteins: the fusion (F) and attachment (G) proteins (van den Hoogen et al., 2001) . As an enveloped virus, hMPV must fuse with the cellular membrane to enter host cells. Recombinant hMPV, avian pneumovirus, and human and bovine respiratory syncytial viruses lacking G can enter host cells and propagate, suggesting that F alone plays an important role in the cellular entry of these viruses (Biacchesi et al., 2004 (Biacchesi et al., , 2005 Skiadopoulos et al., 2006) . Furthermore, ectopic expression of hMPV F has been shown to be sufficient to mediate cellcell fusion, demonstrating the major contribution of F torequired for protein folding and modulation of fusion. As shown in a previous study, all three potential N-glycosylation sites are utilized and each affects cleavage and fusion to varying degrees (Schowalter et al., 2006) . However, the roles of N-linked carbohydrates in the fusion, growth and fitness of hMPV remain largely unknown. In the present study, mutant clones were prepared from the full-length cDNA of wild-type (WT) NL/1/00-GFP virus by preventing N-linked glycosylation at the sites described by Schowalter et al. by mutating the asparagine residues at those sites. After recovery of the recombinant virus, the in vitro and in vivo growth and fitness were compared with those of WT virus. The results showed that all mutants incapable of being N-glycosylated at one or two of these sites were generally less fit in vitro and in immunocompromised mouse lungs to different degrees, causing milder pulmonary histopathology compared with WT virus. Therefore, these mutant viruses may be good candidates for the development of a live attenuated vaccine.
RESULTS

Construction and recovery of WT and mutated rhMPV
Mutations were introduced by using a QuikChange II XL Site-Directed Mutagenesis kit according to the manufacturer's instructions (Fig. 1 ). WT and M1 viruses were propagated three to five times in Vero E6 cells to produce stocks. However, the M2 and M4 viruses were propagated six to eight times because they grew more slowly than WT and M1 viruses. Viral RNA from each mutated virus was subjected to RT-PCR to amplify the F gene, and the products were sequenced to confirm the mutation(s). However, mutant viruses M3, M5, M6 and M7 that lack Nlinked glycosylation at position 353, either individually or together with other sites, could not be recovered. Repeated failures to recover these viruses suggested that this putative N-linked glycosylation site plays an import role in viral growth.
Assessment of hMPV F protein by Western blotting
The F proteins of the WT virus and all mutants were analysed by Western blotting. The F1 subunits of M2 and M4 migrated in the gel faster than those of WT and M1 viruses (Fig. 2a) , demonstrating that residue 172 was possibly N-glycosylated in the recombinant protein.
Similarly, the F2 subunits of M1 and M4 viruses also migrated faster than those of WT and M2 viruses (Fig. 2b) , suggesting that N57 was also a possible glycosylation site. The production of the nucleocapsid protein in WT and all mutant viruses appeared to be comparable (Fig. 2c) , while production of F1 subunits for M2 and M4 was markedly lower in quantity than was observed for M1 and WT viruses, indicating that prevention of glycosylation at position 172 probably affected the production of the F protein.
F protein expression on the infected cell membrane
The efficiency of expression of F protein by WT and mutant viruses on the infected cell membrane was analysed by flow cytometry by detecting phycoerythrin (PE)-labelled cells. As an indicator of viral replication, GFP expression reflected the amount of live virus in the culture system. Very few (,2 %) cells were infected with WT or mutant viruses, as determined by detecting GFP, indicating that the cell membrane was intact at the time of detection. The mean percentages of PE-positive cells of the total mockinfected cell population were, 1.23±0.38, 1.42±0.1, 1.40±0.94 and 0.60±0.08 %, respectively, whereas the percentages of PE-positive cells of total infected cells by WT, M1, M2 and M4 viruses were comparable at 11.43±3.5, 14.82±3.18, 13.40±8.98 and 13.32±7.88 %, respectively, which suggested that the F protein was expressed more highly than GFP. The results indicated that the mutated F protein folded correctly and was expressed properly on the cell membrane.
Sizes of fluorescent plaques of WT and mutated viruses
Vero E6 cells were infected with WT or mutated viruses at an m.o.i. of 0.1 and grown under an agarose overlay. Fluorescent plaques of infected cells were observed under a fluorescence microscope daily after infection. The sizes of the plaques of M1 were similar to those of WT virus at days 2 and 4 after infection. The plaque sizes of M2 and : N57Q  M2: N172Q  M3: N353Q  M4: N57Q+N172Q  M5: N172Q+N353Q  M6: N57Q+N353Q  M7: N57Q+N172Q+N353Q   172  353   SS  HRA  HRB  CT  T  M  F  P   F1 RGD Fig. 1 M4, however, were markedly smaller than those of WT virus and especially of M2 virus (data not shown).
Growth kinetics of WT and mutated viruses in Vero E6 cells and in the lungs of infected mice
The growth of M1 was similar to that of WT in Vero E6 cells, with a peak titre exceeding 10 5 p.f.u. ml 21 on day 4 after inoculation. M2 had a lower growth capacity, with a titre 1 log lower than that of WT. M4 had the lowest growth rate in Vero E6 cells, as shown in Fig. 3(a) .
The viral titre in the lungs of WT-infected BALB/c mice increased gradually and peaked on day 5 post-infection at 5.16±1.09610 5 p.f.u. g 21 and was still detectable on day 9
post-infection at 2.79±1.22610 2 p.f.u. g
21
. Titres in the lungs of M1-infected BALB/c mice also peaked on day 5 post-infection at 1.16±0.04610 5 p.f.u. g 21 and were undetectable on day 9 post-infection. M2 in the lungs of BALB/c mice could not be detected by the plaque assay. Only three M4-infected mice had plaque formation in the lungs on day 3 post-infection (Fig. 3b) .
Fitness assessment of mutated viruses in Vero E6 cells
Competitive replication between each mutant and WT virus in Vero E6 cells was performed to evaluate the replication capacity of the mutated viruses. According to the in vitro growth kinetics, M1 had a slight deficiency, while M2 and M4 were markedly impaired in their capacity to grow, M1 and WT were mixed at a ratio of only 1 : 1, whereas the mixing ratios of M2 and M4 to WT were 1 : 1, 10 : 1, 100 : 1 and 1000 : 1. The RT-PCR products of the progeny were sequenced. Upon visualizing the electropherograms, M1 gradually disappeared from the mixed population until it was undetectable at passage 15 (Fig. 4a ). The 1 : 1 mixture of M2 and WT showed no M2 signal after the first passage, remaining undetectable at the fourth passage. The 10 : 1 mixture of M2 and WT virus showed diminution in the amount of M2 relative to WT virus, and M2 disappeared eight passages later. The 100 : 1 and 1000 : 1 mixtures of M2 and WT viruses revealed no WT signal from passages 1 to 4 (Fig. 4b ). M4 and WT viruses were also mixed at various ratios and passaged ten times. There were no M4 signals in the 1 : 1 mixture. The 10 : 1 mixture of M4 and WT showed a more rapid diminution of M4 than that of M2 at the same ratio; M4 quickly disappeared from the mixture by the fifth passage. The 100 : 1 mixture of M4 and WT revealed almost no signal from WT virus at the first passage. However, it appeared at the second passage, became dominant rapidly and at the eighth passage, no M4 was detected in the mixture. In the 1000 : 1 mixture of M4 and WT, M4 was dominant and no WT was detected at passages 1 and 5 (Fig. 4c) . In parallel experiments, WT, M1, M2 and M4 were passaged ten times alone as controls. The genetic markers for WT, M1, M2 and M4 remained constant after ten passages, indicating that no reversion or recombination occurred during the passages. As shown in Table 1 , with some variability, the results of nucleotide sequencing of individual clones were largely consistent with the results from analysis of the electropherograms of the mixed populations.
In vivo assessment of the fitness of mutated viruses
Because normal BALB/c mice can clear hMPV from their lungs within days, immunosuppressed BALB/c mice were employed to allow prolonged replication of the mixed viruses and assessment of relative fitness. Animals infected with WT or mutated viruses served as controls. When tested 5 days and 2 weeks later, the output viruses were identical to the input viruses in terms of mutated glycosylation sites, as expected. When mixed with WT virus, M2 showed the lowest competitive growth capacity in mouse lung. At an input ratio of 1 : 1, M2 contributed to 29.88 % of the mixed population at 5 days post-infection and only 19.24 % at 2 weeks post-infection. When M1 or M4 competed with WT virus at an input ratio of 1 : 1, the mutants dominated at 5 days post-infection, but WT virus had gradually increased by 2 weeks post-infection. While M4 competed with WT virus at an input ratio of 10 : 1, M4 was fully dominant at both 5 days and 2 weeks post-infection (Table 2 ). In order to confirm these results further, RT-PCR products from the lungs of two animals in each group were cloned (nt 77-681 of the F gene) were determined. As shown in Table 3 , the results of nucleotide sequencing of individual clones were consistent with the analysis of the electropherograms of the mixed populations.
Lung histopathology after infection by WT or mutated viruses
Pulmonary inflammation was assessed by using a scoring system described by Cimolai et al. (1992) . The maximal inflammatory response occurred on day 5 post-infection in all infected mice (Fig. 5) . In the Dulbecco's modified Eagle's medium (DMEM) control group, the mice presented clear alveoli without inflammatory responses around the bronchioles or vessels with a low histopathological score (HPS) (2.50±0.59, n56). WT-and M1-infected mice, in which viruses were detectable by plaque assay, appeared to have swelling of bronchiolar epithelial cells, alveolar dilation and extensive infiltration of lymphocytes and macrophages surrounding both bronchioles and pulmonary blood vessels, indicating a high mean HPS (16.59±2.13, n56; 16.42±2.82, n56, respectively). In the M2-and M4-infected groups, although alveolar dilation, and lymphocyte and macrophage infiltration were also noted, the inflammatory response (12.25±0.74, n56) was significantly milder compared with that of WT-infected mice (12.75±0.50, n56; P,0.05).
DISCUSSION
The members of the family Paramyxoviridae, including the recently identified hMPV, are some of the most important human pathogens. Two major envelope glycoproteins, the G (attachment) and F (fusion) proteins, can promote the processes of viral attachment and virus-cell membrane fusion required for cell entry. Fusion is a major step in viral entry and cell infection. Although common mechanisms for fusion-protein proteolytic activation and membrane fusion promotion have been shown in many paramyxoviruses in recent years, considerable diversity in receptor binding and in potential mechanisms of triggering fusion exist between the various viruses (Smith et al., 2009) . Several studies indicated that proteolysis of the F protein was required for fusion of hMPV with the cell membrane. However, the attachment protein, G, is not necessary for this process, unlike other paramyxoviruses (Ebata et al., 1991; Horvath & Lamb, 1992; Cattaneo & Rose 1993; Deng et al., 1995; Tanabayashi & Compans 1996; Tong & Compans 1999) . The hMPV fusion protein is synthesized as an inactive precursor (F0) which then is cleaved by exogenous trypsin into the fusion-active F1 and F2 domains. The amino acid sequence of hMPV F possesses features of other paramyxovirus F proteins, including a putative cleavage site and potential N-linked glycosylation sites. The high conservation of hMPV F suggests an important role for N-linked glycosylation in fusion. Schowalter et al. (2006) indicated that the hMPV F is N-glycosylated at three sites which promote cell fusion: aa 57 of the F2 subunit, and aa 172 and 353 of the F1 subunit. Each of these glycosylation sites is important for expression, cleavage and fusion. By using syncytium and luciferase reporter-gene fusion assays, fusion promoted by F protein N-linked glycosylation sites for WT and mutant viruses decreased in the order: WT, N57, N172, N353. The levels of cleaved F on the cell surface also reflected this trend. Previously reported findings on the recombinant F protein strongly suggest that N-linked glycosylation is involved in its fusion function (Schowalter et al., 2006) .
Viruses were altered to prevent glycosylation at individual or combined sites of N-linked glycosylation and this was confirmed by Western blotting. The peptide antibodies for the F1 and F2 subunits failed to detect the F0 protein by Western blotting, probably owing to the different conformations of F0, F1 and F2 (Fig. 2) . F protein expression by WT and mutant viruses on the infected cell membrane were comparable. M2 and M4 formed smaller plaques upon examination on days 2 and 4 post-infection, indicating that impairment of fusion was carried through multiple infection cycles and inhibited propagation of the virus. Additionally, the levels of the F1 and F2 subunits of the mutants were significantly lower, particularly the level of F1. Taking the results of the flow cytometry analysis, fluorescent plaque size assay and Western blotting together, we speculate that F1 production was reduced mainly because of impaired proteolytic cleavage of F0 into F1 and F2. The mutated viruses showed distinct growth patterns in Vero E6 cells and in mouse lung compared with WT virus. M1 (N57 mutant) showed slightly decreased growth capacities in vitro and in mouse lung, whereas M2 (N172 mutant) and M4 (N57+N172 mutant) had considerably decreased growth capacities both in vitro and in vivo. Pulmonary pathology of the M2-or M4-infected mice also showed significantly milder lesions than for WT-infected mice, indicating that the attenuation was associated with the genetic alterations.
The fitness of the mutant viruses in vitro and in vivo validated the replication capacity of the mutated virus. During the early passages of the M4 and WT competitive replication in vitro, there was a very small proportion of genotypes that were different from the CAG or AAC/AAT codons at positions 57 or 172 (one was CAG at position 57 and TAG at 172 and the other contained dual peaks of AAC and CAG at position 57 and CAG at 172), which might reflect secondary genetic variations occurring when being passed in a large quantity, because this phenomenon was not observed in the competitive replication experiments using the M4 : WT mixtures of 1 : 1 or 10 : 1. The growth kinetics and competitive replication assay indicated that M1 was a slightly attenuated strain, whereas M2 and M4 were significantly attenuated in vitro. In cyclophosphamidetreated mice, the F gene sequences of the output viruses individually inoculated into the animals were identical to the input viruses. However, in some of the mixtures, a small proportion of F genotypes other than those of the input viruses were found (Table 3) , which may be an artefact of PCR amplification. At the input ratio of 1 : 1, we observe that there was a trend towards WT predominance in the M1:WT mixture over the course of competitive replication because the proportion of WT virus in the mixed population 2 weeks post-infection was slightly greater than that at 5 days postinfection. Similarly, at the input ratios of M2 to WT of 1 : 1 and 10 : 1, the proportion of WT virus 2 weeks post-infection was also greater than that at 5 days post-infection, suggesting that, during competitive replication, WT became predominant in immunocompromised hosts that can permit prolonged viral replication. However, at the input ratios of 1 : 1 and 10 : 1, the proportion of M4 showed contrasting patterns. M4 was present in a greater proportion than WT virus at the beginning and maintained predominance during the competitive replication. This was inconsistent with the in vitro results, which showed a much lower fitness for M4 as compared with WT, indicating the influence of complex factors affecting these viruses during prolonged replication in vivo.
It has been clearly demonstrated that WT hMPV F protein is not cleaved by an endogenous protease when expressed in Vero cells, but a proteolytic process is necessary for membrane fusion. It is also well known that hMPV F-protein-mediated fusion requires exposure to low pH in order to induce appreciable cell-cell fusion. This raises the possibility that hMPV may be unique among paramyxoviruses, and that it primarily enters cells upon receptor engagement at the plasma membrane. An endocytic/ endosomal pathway by which hMPV enters cells and how N-linked glycosylation is involved in the structure and functions of the F protein should be investigated further.
Nevertheless, our results demonstrate that N-linked carbohydrates are crucial for the fusion function and that this may provide important clues towards the development of antiviral drugs and live attenuated vaccines. Since the production of fusogenic subunit F1 was significantly reduced, it is possible that the production of F0 was reduced because of improper folding and/or impaired proteolysis. The latter is more likely, since in a previous study proteolysis of the recombinant protein without glycosylation of residue 172 could barely be detected in the Western blot assay (Schowalter et al., 2006) . How the N-linked carbohydrates affect the proteolysis process of F is unknown currently and further studies are needed to address this issue.
METHODS
Cells and viruses. Vero E6 cells were grown in DMEM supplemented with 5 % FBS (Gibco), 2 mM L-glutamine, 100 mg streptomycin ml 21 and 100 IU penicillin ml 21 (Gibco). Cultivation of BSR T7/5 cells (Buchholz et al., 1999) and hMPV propagation were performed as described by Herfst et al. (2004) .
Mutagenesis of the F gene and recovery of recombinant WT and mutated hMPV. The full-length hMPV/NL/1/00 cDNA plasmid with GFP inserted between P and M protein genes of the viral genome, and four helper plasmids pCITE-N, pCITE-P, pCITE-L and pCITE-M2.1 containing the N, P, L and M2.1 ORFs of NL/1/00, respectively, were kindly provided by Professor Fouchier (Erasmus Medical Center, Netherlands). Proteolytic cleavage of the NL/100 F protein does not require supplementing with exogenous trypsin. The asparagines of hMPV F at aa 57, 172 and 353 (Fig. 1) were predicted to be the potential N-linked glycosylation sites by an analysis using NetNGlyc 1.0 Server (http://www.cbs.dtu.dk/services/). Each of these asparagines was mutated to glutamine individually or together using a QuikChange mutagenesis kit (Stratagene). The mutations were created according to the manufacturer's instructions using two complementary primers: 00-57F (59-GGTAGGCGATGTAGAGCA-GCTTACATGTGCCGATGG-39) and 00-57R (59-CCATCGGCAC-ATGTAAGCTGCTCTACATCGCCTACC-39) for hMPV F at aa 57; 00-172F (59-GATTTTGTGAGCAAGCAGCTAACACGTGCAATCA-AC-39), and 00-172R (59-GTTGATTGCACGTGTTAGCTGCTTGCT-CACAAAATC-39) for hMPV F at aa 172; and 00-353F (59-GCAGTCAAAGGAGTGCAACATACAGATATCTACTACTAATTA-CCC-39) and 00-353R (59-GGGTAATTAGTAGTAGATATCTGTA-TGTTGCACTCCTTTGACTGC-39) for hMPV F at aa 353. (Mutated nucleotides are in boldface type).
Recovery of recombinant hMPV expressing GFP was performed as described previously (de Graaf et al., 2007) . M1 to M7 represent viruses which lack glycosylation at the following position(s) of the F protein: 57 only, 172 only, 353 only, 57 and 172, 172 and 353, 57 and 353, or 57, 172 and 353 . The F gene of mutant plasmids or rescued hMPV was sequenced to confirm the absence of unexpected mutations at other sites.
Western blot analysis of hMPV F protein. Vero E6 cells in T75 flasks were infected with WT hMPV or mutant recombinant hMPV at an m.o.i. of 0.1 and incubated at 37 uC for 6 days. The cell suspensions were collected, and purified virions were harvested by sucrose-gradient ultracentrifugation (Olszewska-Pazdrak et al., 1998) . The lysates were separated by electrophoresis on a 12 % polyacrylamide gel, transferred to a PVDF membrane (Millipore) and probed with a rabbit anti-hMPV F antibody (kindly provided by Dr Yan Li, Canadian Science Centre for Human and Animal Health, Winnipeg, Canada) diluted 1 : 500 in PBS (pH 7.2) Tween-20 (PBST) containing 10 % BSA, followed by incubation with HRP-conjugated goat antirabbit antibody diluted 1 : 10 000 in PBST. hMPV F was replaced with hMPV N as a control. The membranes were developed with a Visualizer Western blot detection kit (Millipore) and visualized using Quantity One software (Bio-Rad). For F protein staining, the primary antibody was a rabbit anti-hMPV F1 peptide antibody (kindly provided by Dr Yan Li, Winnipeg, Canada) diluted 1 : 300 in PBS containing 10 % BSA, followed by incubation with a PE-conjugated goat anti-rabbit antibody (SiZhengBai, China). The cells were fixed and detected by flow cytometry. This experiment was repeated three times; the mean frequency of the PE-positive cells was used to represent the efficiency of F-protein expression. In vitro growth kinetics and plaque formation capacity of recombinant viruses. Vero E6 cells were seeded in 35 mm dishes 1 day prior to inoculation at an m.o.i. of 0.1. After adsorption, the inoculum was removed and cells were washed twice with medium followed by incubation in fresh medium at 37 uC. Then, 1 ml of medium was collected from each dish at 24 h intervals for up to 6 days. Plaque assays were performed to determine the viral titres (p.f.u. ml 21 ). Meanwhile, during viral passaging under an agarose overlay, the plaque-formation capacity of WT and mutated viruses were assessed daily.
Competitive replication of virus in cells. Mixtures of WT and mutated viruses were inoculated into Vero E6 cells in 35 mm dishes, and competitive replication was used to evaluate the relative fitnesses of the mutated viruses. According with the in vitro growth kinetics, M1 was tested at a ratio of mutated virus to WT virus of 1 : 1 at an m.o.i. of 0.1. M2 and M4 were tested at different ratios of mutated virus to WT virus (1 : 1, 10 : 1, 100 : 1 and 1000 : 1), maintaining a cumulative m.o.i. of 0.1. The passaging process was continued for 10 to 18 passages. RNA was extracted from the infected Vero E6 cells at every two or three passages passage. WT, M1, M2 and M4 viruses were passaged individually as controls.
RT-PCR, nucleotide sequence analysis and determination of relative amounts of F gene transcript in mixed viruses. Total RNA was extracted from infected Vero E6 cells using an EZgeno total RNA extraction kit (Genemega). The F gene was amplified with primers 3054F (59-GTCTTGGAAAGTGGTGATCAT-39) and 4285R (59-ACTGTGTCTGCGTCTTGGTT-39), spanning the F gene from nt 2-1253. Visualization of the electropherograms and calculation of relative proportions of the wild type and mutated bases were used to assess the viral mixtures. In the RT-PCR products of the M1 and WT mixture, the positions corresponding to aa 57 of the F gene were analysed, wherein the codon AAC (asparagine) indicated WT virus and codon CAG (glutamine) indicated M1 virus. The heights of the peaks for adenine (A) and cytosine (C) or C and guanine (G) of position 57 were measured using EDIT (PE Applied Biosystems), and the proportion of M1 in the mixture was obtained by dividing the sum of the C and G peak heights by the sum of the A, C, and C and G peak heights. For the M2 and WT virus mixture, the codon AAT (asparagine) indicated WT virus and codon CAG (glutamine) indicated M2 virus. The proportion of M2 present was also determined by dividing the sum of the C and G peak heights by the sum of the A, thymine (T), C and G peak heights. M4 contained two mutation sites at positions 57 and 172 of the F protein. Therefore, the proportion of M4 in the M4 : WT mixture was assessed by dividing the sum of C and G peak heights at position 57 plus the C and G heights at position 172 by the sum of the A, C, C and G peak heights at position 57 and the A, T, C and G peak heights at position 172.
To validate the relative amounts of WT and mutated viruses further, 604 bp RT-PCR products (nt 77 to 681 in the F gene) from the serially passaged mixed viral populations were cloned into a pMD 18-T vector (TaKaRa). Approximately 20 colonies were selected, and the cloned sequences were determined. The proportion of mutated and WT genotypes in each population was calculated.
Replication kinetics of WT and mutated viruses in mouse lungs and histopathology. A total of 150 female BALB/c mice (specific pathogen-free) aged~6-8 weeks were purchased and housed under pathogen-free conditions in the Animal Center of Chongqing Medical University. Mice were randomly assigned to five groups: WT-infected, M1-infected, M2-infected, M4-infected and DMEM-control groups. Under anaesthesia, these infected mice were intranasally inoculated with 1.5610 6 p.f.u. WT, M1, M2 or M4 virus (100 ml). Mice in the control group were treated with 100 ml of DMEM. Six mice from each group were sacrificed at days 1, 3, 5, 7 and 9 post-inoculation, and the lungs were collected. The left lungs were histopathologically examined, and the right lungs were weighed, homogenized on ice in 10 volumes of Hank's balanced salt solution containing 0.218 M sucrose, 25 mM HEPES, 4.8 mM L-glutamate, 200 IU penicillin ml 21 and 200 mg streptomycin ml 21 (pH 7.4). Monolayers of Vero E6 cells were used for viral titration when the cell confluency reached 80 %. Homogenates were serially diluted, plated on Vero E6 cells and adsorbed for 2 h. The overlays containing equal volumes of DMEM supplemented with 0.25 % SeaPlaque GTG agarose (Lonza) and 2 % FBS were added to the wells. After 4 days of incubation at 37 uC, green fluorescent plaques were counted under a fluorescence microscope. The resulting titre of each sample was divided by the lung weight and reported as p.f.u. g 21 . The left lungs were fixed in 4 % formaldehyde, embedded in paraffin, sectioned into 4 mm sections and stained with haematoxylin-eosin (H&E). The HPS was determined using the method described by Cimolai et al. (1992) .
Animal model for competitive replication. A total of 154 BALB/c mice were intraperitoneally injected with 50 mg cyclophosphamide kg 21 (CY; Sigma) three times per week for at least 3 weeks prior to viral challenge until the end of the study. As previously described, this treatment led to marked leucopenia, with a reduction of .80 % in total white blood cell count compared with animals without CY treatment (Johnson et al., 1982; Ottolini et al., 2002; Zhao et al., 2004) . Under anaesthesia, mice were infected intranasally with 1.5610 6 p.f.u. virus. Groups 1-4 received WT, M1, M2 and M4, respectively. Groups 4-9 were treated with a mixtures of WT and M1 (1 : 1), WT and M2 (1 : 1), WT and M2 (1 : 10), WT and M4 (1 : 1) and WT and M4 (1 : 10), respectively. Mice in each group were sacrificed at 5 days and 2 weeks after infection. Lungs were collected followed by viral RNA extraction. RT-PCR, nucleotide sequence analysis and determination of relative amounts of RNA species as described above.
